#news #biotech Genfit’s elafibranor hits goal in phase 2 PBC trial

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Genfit’s elafibranor hits goal in phase 2 PBC trial .A phase 2 trial of Genfit’s elafibranor in primary biliary cholangitis (PBC) has hit its primary endpoint. The readout sets Genfit up to start a pivotal trial in PBC and thereby expand its late-phase pipeline beyond NASH.

from FierceBiotech: Biotech https://ift.tt/2PrNfw4